
ObesityWeek 2026: Once-weekly semaglutide reduced BMI by 13.5% vs a 2.7% gain with placebo at 68 weeks in children 6 to <12 years with obesity.
A summary of new data presented at the 2024 American College of Allergy, Asthma & Immunology Annual Scientific Meeting.
ARS Pharmaceuticals is presenting new data October 25 on the first
These presentations will showcase a number of posters covering topics such as cardiovascular safety, human factor research for emergency readiness, and real-world data in pediatric patients.
The above slideshow features a snapshot of the presentations being featured at the ACAAI meeting, with links to view the posters.






